Atlas Trials

Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease

Clinical trial NCT00058773 · TERMINATED

Trial details

NCT number
NCT00058773
Sponsor
Baylor College of Medicine
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Hodgkin DiseaseNon-Hodgkins Lymphoma
Start date
1996-01-01
Primary completion
2002-04-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.